BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33883194)

  • 41. Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Orchard TJ; Backlund JC; Costacou T; Cleary P; Lopes-Virella M; Levy AP; Lachin JM;
    J Diabetes Complications; 2016; 30(8):1577-1584. PubMed ID: 27539884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testosterone Concentrations and Cardiovascular Autonomic Neuropathy in Men with Type 1 Diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC).
    Kim C; Pop-Busui R; Braffett B; Cleary PA; Bebu I; Wessells H; Orchard T; Sarma AV;
    J Sex Med; 2015 Nov; 12(11):2153-9. PubMed ID: 26559501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications).
    Pop-Busui R; Cleary PA; Braffett BH; Martin CL; Herman WH; Low PA; Lima JAC; Bluemke DA;
    J Am Coll Cardiol; 2013 Jan; 61(4):447-454. PubMed ID: 23265339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial.
    Verma S; Bain SC; Buse JB; Idorn T; Rasmussen S; Ørsted DD; Nauck MA
    JAMA Cardiol; 2019 Dec; 4(12):1214-1220. PubMed ID: 31721979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience.
    Molitch ME; Gao X; Bebu I; de Boer IH; Lachin J; Paterson A; Perkins B; Saenger AK; Steffes M; Zinman B;
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):854-861. PubMed ID: 31123181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
    Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
    JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
    Ferdinand KC; Botros FT; Atisso CM; Sager PT
    Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Braffett BH; de Boer IH; Aiello LP; Bantle JP; Lorenzi GM; Herman WH; Gubitosi-Klug RA; Perkins BA; Lachin JM; Molitch ME
    Diabetes Care; 2023 Feb; 46(2):361-368. PubMed ID: 36520643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of common and coding variants with cardiovascular disease in the Diabetes Heart Study.
    Adams JN; Raffield LM; Freedman BI; Langefeld CD; Ng MC; Carr JJ; Cox AJ; Bowden DW
    Cardiovasc Diabetol; 2014 Apr; 13():77. PubMed ID: 24725463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Nathan DM
    Diabetologia; 2021 May; 64(5):1049-1058. PubMed ID: 33550441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of a cardiovascular disease genetic risk score in the Diabetes Heart Study.
    Raffield LM; Cox AJ; Carr JJ; Freedman BI; Hicks PJ; Langefeld CD; Hsu FC; Bowden DW
    Acta Diabetol; 2015 Aug; 52(4):743-51. PubMed ID: 25700702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes.
    Habes M; Jacobson AM; Braffett BH; Rashid T; Ryan CM; Shou H; Cui Y; Davatzikos C; Luchsinger JA; Biessels GJ; Bebu I; Gubitosi-Klug RA; Bryan RN; Nasrallah IM;
    JAMA Netw Open; 2023 Jun; 6(6):e2316182. PubMed ID: 37261829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
    Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RISK FACTORS FOR HEARING IMPAIRMENT IN TYPE 1 DIABETES.
    Braffett BH; Lorenzi GM; Cowie CC; Gao X; Bainbridge KE; Cruickshanks KJ; Kramer JR; Gubitosi-Klug RA; Larkin ME; Barnie A; Lachin JM; Schade DS;
    Endocr Pract; 2019 Dec; 25(12):1243-1254. PubMed ID: 31412233
    [No Abstract]   [Full Text] [Related]  

  • 56. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropathy in the DCCT/EDIC-What Was Done Then and What We Would Do Better Now.
    Pop-Busui R; Martin C
    Int Rev Neurobiol; 2016; 127():9-25. PubMed ID: 27133142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
    Leiter LA; Bain SC; Hramiak I; Jódar E; Madsbad S; Gondolf T; Hansen T; Holst I; Lingvay I
    Cardiovasc Diabetol; 2019 Jun; 18(1):73. PubMed ID: 31167654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Low-Expression Variant of
    Dahlström EH; Saksi J; Forsblom C; Uglebjerg N; Mars N; Thorn LM; Harjutsalo V; Rossing P; Ahluwalia TS; Lindsberg PJ; Sandholm N; Groop PH;
    Diabetes; 2021 Oct; 70(10):2391-2401. PubMed ID: 34244239
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.